| Hans-Günter Meyer-Thompson | Morphin ret.
Risk assessment of using off-label morphine sulfate in a population-based retrospective cohort of opioid-dependent patients.
Risk assessment of using off-label morphine sulfate in a population-based retrospective cohort of opioid-dependent patients.
Bertin C, Delorme J, Riquelme M, Peyrière H, Brousse G, Eschalier A, Ardid D, Chenaf C, Authier N.
Br J Clin Pharmacol. 2019 Aug 6. doi: 10.1111/bcp.14082.
https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.14082